Surgical Sealants, Adhesives and Hemostats Global Market - Forecast to 2029
Surgical sealants, adhesives, and hemostats (SAH) are the products used to close surgical incisions, post-surgical application, block the passage of fluids through the surface or openings of the wounds, and also to avoid microbial adhesions and infections. Sealants and adhesives are usually considered together as they both adhere to and seal the surgical incisions, while, hemostats are used to achieve hemostasis when the conventional method is ineffective and impractical.
According to IQ4I analysis, the SAH global market is expected to grow at mid-single digit CAGR from 2022 to 2029 to reach $4,366.0 million by 2029. The SAH global market is mainly segmented based on products, applications, end-users, and based on geography. The product market is segmented into sealant, adhesive and hemostat. Among these, the hemostat accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029. The sealants are further segmented based on their origin into natural and synthetic sealants. The synthetic sealant accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029. The natural sealants are further sub-segmented based on composition into fibrin and albumin sealants. Among them, fibrin accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. The synthetic sealants are further segmented based on composition into cyanoacrylate, hydrogels, and others. Among them, hydrogels accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029. The adhesive market is segmented into natural and synthetic adhesives, among them; synthetic adhesives accounted for the largest revenue in 2022 and are expected to grow at low-single digit CAGR from 2022 to 2029. The natural adhesives are further sub-segmented based on composition into fibrin and albumin, among them, fibrin adhesive accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. The synthetic adhesives are further segmented based on composition into cyanoacrylate and polyurethane. The cyanoacrylate adhesive accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. Hemostats are classified based on function into mechanical hemostats, active hemostats, flowable hemostats, and fibrin sealants hemostats, among them, the mechanical hemostats accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029. Fibrin sealant hemostat is the fastest growing segment at high-single digit strong CAGR from 2022 to 2029 because it is unique, powerful and effective for localized and diffused bleeding during surgical procedures.
The application market is segmented into Cardiovascular surgery, General Surgery, Orthopedic surgery, Urology, Pulmonology, Neurosurgery, Gynecology, Cosmetic surgery and Others. The general surgery segment accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029, because of high demand for various surgical procedures. Cosmetic surgery is the fastest growing segment at high-single digit CAGR, because of the advancements in treatment regimes available and better cosmetic outcomes.
The end-users market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment accounted for the largest share in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029, due to an increase in the aging population, increase in surgical procedural volumes, and better patient care services with advanced facilities.
Some of the major players in the SAH market include Baxter International Inc. (U.S.), Johnson & Johnson (Ethicon) (U.S.), Becton, Dickinson & Company (C.R.Bard) (U.S.), Integra Lifescience (U.S.), B.Braun Melsungen AG (Germany), Teleflex (U.S.), Medtronic Plc (Ireland), Artivion Inc. (Cryolife) (U.S.), Advanced Medical Solutions Group Plc (U.K.), Tissium (France), Corza Medical, Inc. (U.S.), Healthium (India), Meril Lifesciences (India), Hemostasis (U.S.), Stryker (U.S.), and Terumo (Japan).
According to IQ4I analysis, the SAH global market is expected to grow at mid-single digit CAGR from 2022 to 2029 to reach $4,366.0 million by 2029. The SAH global market is mainly segmented based on products, applications, end-users, and based on geography. The product market is segmented into sealant, adhesive and hemostat. Among these, the hemostat accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029. The sealants are further segmented based on their origin into natural and synthetic sealants. The synthetic sealant accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029. The natural sealants are further sub-segmented based on composition into fibrin and albumin sealants. Among them, fibrin accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. The synthetic sealants are further segmented based on composition into cyanoacrylate, hydrogels, and others. Among them, hydrogels accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029. The adhesive market is segmented into natural and synthetic adhesives, among them; synthetic adhesives accounted for the largest revenue in 2022 and are expected to grow at low-single digit CAGR from 2022 to 2029. The natural adhesives are further sub-segmented based on composition into fibrin and albumin, among them, fibrin adhesive accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. The synthetic adhesives are further segmented based on composition into cyanoacrylate and polyurethane. The cyanoacrylate adhesive accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. Hemostats are classified based on function into mechanical hemostats, active hemostats, flowable hemostats, and fibrin sealants hemostats, among them, the mechanical hemostats accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029. Fibrin sealant hemostat is the fastest growing segment at high-single digit strong CAGR from 2022 to 2029 because it is unique, powerful and effective for localized and diffused bleeding during surgical procedures.
The application market is segmented into Cardiovascular surgery, General Surgery, Orthopedic surgery, Urology, Pulmonology, Neurosurgery, Gynecology, Cosmetic surgery and Others. The general surgery segment accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029, because of high demand for various surgical procedures. Cosmetic surgery is the fastest growing segment at high-single digit CAGR, because of the advancements in treatment regimes available and better cosmetic outcomes.
The end-users market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment accounted for the largest share in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029, due to an increase in the aging population, increase in surgical procedural volumes, and better patient care services with advanced facilities.
Some of the major players in the SAH market include Baxter International Inc. (U.S.), Johnson & Johnson (Ethicon) (U.S.), Becton, Dickinson & Company (C.R.Bard) (U.S.), Integra Lifescience (U.S.), B.Braun Melsungen AG (Germany), Teleflex (U.S.), Medtronic Plc (Ireland), Artivion Inc. (Cryolife) (U.S.), Advanced Medical Solutions Group Plc (U.K.), Tissium (France), Corza Medical, Inc. (U.S.), Healthium (India), Meril Lifesciences (India), Hemostasis (U.S.), Stryker (U.S.), and Terumo (Japan).
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing demand for surgical procedures boosts sah market growth
3.3.1.2 The emergence of technically advanced products
3.3.1.3 Increasing geriatric population
3.3.1.4 Acquisition to open an array of opportunities for the market to flourish
3.3.1.5 Acceptance of sah and market expansion in emerging nations
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Pitfalls in the usage of sah
3.3.2.2 Expensive sah impeding effective penetration in low and middle-income countries
3.3.2.3 Unfavorable reimbursement policies in developing nations
3.3.2.4 Stringent regulatory guidelines
3.3.2.5 Availability of alternative products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
3.4.1.2 ISO 14644-1 CLEANROOM STANDARDS
3.4.1.3 ISO 13485 MEDICAL DEVICES
3.4.1.4 ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
3.4.2 ASTM INTERNATIONAL STANDARDS
3.4.3 U.S.
3.4.4 CANADA
3.4.5 EUROPE
3.4.6 JAPAN
3.4.7 CHINA
3.4.8 INDIA
3.5 TECHNOLOGICAL ADVANCEMENTS
3.5.1 BIOGLUE
3.5.2 BIOINSPIRED GLUE FROM BARNACLES
3.5.3 SNAKE-DERIVED SUPER GLUE
3.5.4 ALGA MIMETIC TECHNOLOGY
3.5.5 A POLYMER PATCH FOR THE ABDOMINAL CAVITY
3.6 CLINICAL TRIALS
3.7 FUNDING SCENARIO
3.8 PORTER’S FIVE FORCE ANALYSIS
3.8.1 THREAT OF NEW ENTRANTS
3.8.2 THREAT OF SUBSTITUTES
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 BARGAINING POWER OF BUYERS
3.8.5 RIVALRY AMONG EXISTING COMPETITORS
3.9 SUPPLY CHAIN ANALYSIS
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.1 SAH GLOBAL MARKET SHARE ANALYSIS
3.10.2 SURGICAL SEALANTS GLOBAL MARKET SHARE ANALYSIS
3.10.3 SURGICAL ADHESIVES GLOBAL MARKET SHARE ANALYSIS
3.10.4 HEMOSTATS GLOBAL MARKET SHARE ANALYSIS
3.11 SAH COMPANY MATRIX
4 SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON PRODUCT
4.1 INTRODUCTION
4.2 SEALANTS
4.2.1 NATURAL SEALANTS
4.2.1.1 Fibrin natural sealants
4.2.1.2 Albumin natural sealants
4.2.2 SYNTHETIC SEALANTS
4.2.2.1 Cyanoacrylate
4.2.2.2 Hydrogels
4.2.2.3 Others
4.3 ADHESIVES
4.3.1 NATURAL ADHESIVES
4.3.1.1 Fibrin natural adhesives
4.3.1.2 Albumin natural adhesives
4.3.2 SYNTHETIC ADHESIVES
4.3.2.1 Cyanoacrylate
4.3.2.2 Polyurethane
4.4 HEMOSTATS
4.4.1 MECHANICAL HEMOSTATS
4.4.2 ACTIVE HEMOSTATS
4.4.3 FLOWABLE HEMOSTATS
4.4.4 FIBRIN SEALANT HEMOSTATS
5 SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON APPLICATION
5.1 INTRODUCTION
5.2 CARDIOVASCULAR SURGERY
5.3 GENERAL SURGERY
5.4 ORTHOPEDIC SURGERY
5.5 UROLOGY
5.6 PULMONOLOGY
5.7 NEUROSURGERY
5.8 GYNECOLOGY
5.9 COSMETIC SURGERY
5.10 OTHERS
6 SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTERS
6.4 OTHERS
7 SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 THE U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 THE U.K.
7.3.3 FRANCE
7.3.4 REST OF E.U.
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 ROW
7.5.1 BRAZIL
7.5.2 REST OF LATAM
7.5.3 MIDDLE EAST AND OTHERS
8 MAJOR COMPANIES
8.1 ADVANCED MEDICAL SOLUTIONS
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 ARTIVION
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 BAXTER INTERNATIONAL, INC
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 B.BRAUN MELSUNGEN AG
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 BECTON, DICKINSON AND COMPANY (C.R.BARD INC.)
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 CORZA MEDICAL
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 INTEGRA LIFESCIENCE
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 JOHNSON & JOHNSON (ETHICON)
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 MEDTRONIC, PLC
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 TELEFLEX
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing demand for surgical procedures boosts sah market growth
3.3.1.2 The emergence of technically advanced products
3.3.1.3 Increasing geriatric population
3.3.1.4 Acquisition to open an array of opportunities for the market to flourish
3.3.1.5 Acceptance of sah and market expansion in emerging nations
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Pitfalls in the usage of sah
3.3.2.2 Expensive sah impeding effective penetration in low and middle-income countries
3.3.2.3 Unfavorable reimbursement policies in developing nations
3.3.2.4 Stringent regulatory guidelines
3.3.2.5 Availability of alternative products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
3.4.1.2 ISO 14644-1 CLEANROOM STANDARDS
3.4.1.3 ISO 13485 MEDICAL DEVICES
3.4.1.4 ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
3.4.2 ASTM INTERNATIONAL STANDARDS
3.4.3 U.S.
3.4.4 CANADA
3.4.5 EUROPE
3.4.6 JAPAN
3.4.7 CHINA
3.4.8 INDIA
3.5 TECHNOLOGICAL ADVANCEMENTS
3.5.1 BIOGLUE
3.5.2 BIOINSPIRED GLUE FROM BARNACLES
3.5.3 SNAKE-DERIVED SUPER GLUE
3.5.4 ALGA MIMETIC TECHNOLOGY
3.5.5 A POLYMER PATCH FOR THE ABDOMINAL CAVITY
3.6 CLINICAL TRIALS
3.7 FUNDING SCENARIO
3.8 PORTER’S FIVE FORCE ANALYSIS
3.8.1 THREAT OF NEW ENTRANTS
3.8.2 THREAT OF SUBSTITUTES
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 BARGAINING POWER OF BUYERS
3.8.5 RIVALRY AMONG EXISTING COMPETITORS
3.9 SUPPLY CHAIN ANALYSIS
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.1 SAH GLOBAL MARKET SHARE ANALYSIS
3.10.2 SURGICAL SEALANTS GLOBAL MARKET SHARE ANALYSIS
3.10.3 SURGICAL ADHESIVES GLOBAL MARKET SHARE ANALYSIS
3.10.4 HEMOSTATS GLOBAL MARKET SHARE ANALYSIS
3.11 SAH COMPANY MATRIX
4 SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON PRODUCT
4.1 INTRODUCTION
4.2 SEALANTS
4.2.1 NATURAL SEALANTS
4.2.1.1 Fibrin natural sealants
4.2.1.2 Albumin natural sealants
4.2.2 SYNTHETIC SEALANTS
4.2.2.1 Cyanoacrylate
4.2.2.2 Hydrogels
4.2.2.3 Others
4.3 ADHESIVES
4.3.1 NATURAL ADHESIVES
4.3.1.1 Fibrin natural adhesives
4.3.1.2 Albumin natural adhesives
4.3.2 SYNTHETIC ADHESIVES
4.3.2.1 Cyanoacrylate
4.3.2.2 Polyurethane
4.4 HEMOSTATS
4.4.1 MECHANICAL HEMOSTATS
4.4.2 ACTIVE HEMOSTATS
4.4.3 FLOWABLE HEMOSTATS
4.4.4 FIBRIN SEALANT HEMOSTATS
5 SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON APPLICATION
5.1 INTRODUCTION
5.2 CARDIOVASCULAR SURGERY
5.3 GENERAL SURGERY
5.4 ORTHOPEDIC SURGERY
5.5 UROLOGY
5.6 PULMONOLOGY
5.7 NEUROSURGERY
5.8 GYNECOLOGY
5.9 COSMETIC SURGERY
5.10 OTHERS
6 SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTERS
6.4 OTHERS
7 SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 THE U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 THE U.K.
7.3.3 FRANCE
7.3.4 REST OF E.U.
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 ROW
7.5.1 BRAZIL
7.5.2 REST OF LATAM
7.5.3 MIDDLE EAST AND OTHERS
8 MAJOR COMPANIES
8.1 ADVANCED MEDICAL SOLUTIONS
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 ARTIVION
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 BAXTER INTERNATIONAL, INC
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 B.BRAUN MELSUNGEN AG
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 BECTON, DICKINSON AND COMPANY (C.R.BARD INC.)
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 CORZA MEDICAL
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 INTEGRA LIFESCIENCE
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 JOHNSON & JOHNSON (ETHICON)
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 MEDTRONIC, PLC
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 TELEFLEX
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 2 SAH GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
TABLE 3 SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 4 SEALANTS GLOBAL MARKET REVENUE, BASED ON ORIGIN, (2021-2029) ($MN)
TABLE 5 NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 6 NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 7 FIBRIN NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 8 ALBUMIN NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 9 SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 10 SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 11 CYANOACRYLATE SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 12 HYDROGEL SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 13 OTHER SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 14 ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 15 ADHESIVES GLOBAL MARKET REVENUE, BASED ON ORIGIN, (2021-2029) ($MN)
TABLE 16 NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 17 NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 18 FIBRIN NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 19 ALBUMIN NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 20 SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 21 SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 22 CYANOACRYLATE SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 23 POLYURETHANE SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 24 HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 25 HEMOSTATS GLOBAL MARKET REVENUE, BASED ON FUNCTION, (2021-2029) ($MN)
TABLE 26 MECHANICAL HEMOSTAT GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 27 ACTIVE HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 28 FLOWABLE HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 29 FIBRIN SEALANT HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 30 SAH GLOBAL MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
TABLE 31 CARDIOVASCULAR SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 32 GENERAL SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 33 ORTHOPEDIC SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 34 UROLOGY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 35 PULMONOLOGY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 36 NEUROSURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 37 GYNECOLOGY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 38 COSMETIC SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 39 OTHER SAH APPLICATIONS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 40 SAH GLOBAL MARKET REVENUE, BASED ON END-USERS,(2021-2029) ($MN)
TABLE 41 HOSPITALS SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 42 AMBULATORY SURGICAL CENTERS SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 43 OTHER END-USERS SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 44 SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 45 NORTH AMERICA SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
TABLE 46 NORTH AMERICA SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 47 NORTH AMERICA NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 48 NORTH AMERICA SYNTHETIC SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 49 NORTH AMERICA ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 50 NORTH AMERICA NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 51 NORTH AMERICA SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 52 NORTH AMERICA HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
TABLE 53 NORTH AMERICA SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
TABLE 54 NORTH AMERICA SAH MARKET REVENUE, BASED ON END-USERS, (2021-2029) ($MN)
TABLE 55 NORTH AMERICA SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
TABLE 56 EUROPE SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
TABLE 57 EUROPE SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 58 EUROPE NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 59 EUROPE SYNTHETIC SEALANTS MARKET REVENUE,BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 60 EUROPE ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 61 EUROPE NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 62 EUROPE SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 63 EUROPE HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
TABLE 64 EUROPE SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
TABLE 65 EUROPE SAH MARKET REVENUE, BASED ON END-USERS,(2021-2029) ($MN)
TABLE 66 EUROPE SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
TABLE 67 APAC SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
TABLE 68 APAC SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 69 APAC NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 70 APAC SYNTHETIC SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 71 APAC ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 72 APAC NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 73 APAC SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 74 APAC HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
TABLE 75 APAC SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
TABLE 76 APAC SAH MARKET REVENUE, BASED ON END USERS, (2021-2029) ($MN)
TABLE 77 APAC SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
TABLE 78 ROW SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
TABLE 79 ROW SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 80 ROW NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 81 ROW SYNTHETIC SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 82 ROW ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 83 ROW NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 84 ROW SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 85 ROW HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
TABLE 86 ROW SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
TABLE 87 ROW SAH MARKET REVENUE, BASED ON END-USERS, (2021-2029) ($MN)
TABLE 88 ROW SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
TABLE 89 ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 90 ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE, BASED ON SEGMENTS, (2019-2021) ($MN)
TABLE 91 ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE, BASED ON SUBSEGMENTS, (2019-2021) ($MN)
TABLE 92 ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE, BASED ON GEOGRAPHY, (2019-2021) ($MN)
TABLE 93 ARTIVION: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
TABLE 94 ARTIVION: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 95 ARTIVION: TOTAL REVENUE, BASED ON SUBSEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 96 ARTIVION: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
TABLE 97 BAXTER INTERNATIONAL, INC.: TOTAL SALES AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
TABLE 98 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 99 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
TABLE 100 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 101 B.BRAUN MELSENGEN AG: TOTAL REVENUE, BASED ON SEGMENTS, (2019-2021) ($MN)
TABLE 102 B.BRAUN MELSENGEN, AG: TOTAL REVENUE, BASED ON GEOGRAPHY, (2019-2021) ($MN)
TABLE 103 BD: TOTAL REVENUE AND R&D EXPENSES, (2020-2022)(Q2) ($MN)
TABLE 104 BD: TOTAL REVENUE BASED ON SEGMENTS, (2020-2022)(Q2) ($MN)
TABLE 105 BD: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q2) ($MN)
TABLE 106 INTEGRA LIFESCIENCE: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
TABLE 107 INTEGRA LIFESCIENCE: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 108 INTEGRA LIFESCIENCE: TOTAL REVENUE, BASED ON SUB-SEGMENTS, (2020-2022)(Q1) ($MN)
TABLE 109 INTEGRA LIFESCIENCE: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
TABLE 110 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
TABLE 111 JOHNSON & JOHNSON: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 112 JOHNSON & JOHNSON: TOTAL REVENUE, BASED ON SUBSEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 113 JOHNSON & JOHNSON: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
TABLE 114 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) ($MN)
TABLE 115 MEDTRONIC, PLC: TOTAL REVENUE, BASED ON SEGMENTS (2020-2022) ($MN)
TABLE 116 MEDTRONIC, PLC: TOTAL REVENUE, BASED ON SUB-SEGMENTS, (2020-2022) ($MN)
TABLE 117 MEDTRONIC, PLC: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) ($MN)
TABLE 118 TELEFLEX: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q2) ($MN)
TABLE 119 TELEFLEX: TOTAL REVENUE, BASED ON SEGMENTS,(2020-2022) (Q2) ($MN)
TABLE 120 TELEFLEX: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
TABLE 1 SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 2 SAH GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
TABLE 3 SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 4 SEALANTS GLOBAL MARKET REVENUE, BASED ON ORIGIN, (2021-2029) ($MN)
TABLE 5 NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 6 NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 7 FIBRIN NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 8 ALBUMIN NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 9 SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 10 SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 11 CYANOACRYLATE SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 12 HYDROGEL SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 13 OTHER SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 14 ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 15 ADHESIVES GLOBAL MARKET REVENUE, BASED ON ORIGIN, (2021-2029) ($MN)
TABLE 16 NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 17 NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 18 FIBRIN NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 19 ALBUMIN NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 20 SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 21 SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 22 CYANOACRYLATE SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 23 POLYURETHANE SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 24 HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 25 HEMOSTATS GLOBAL MARKET REVENUE, BASED ON FUNCTION, (2021-2029) ($MN)
TABLE 26 MECHANICAL HEMOSTAT GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 27 ACTIVE HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 28 FLOWABLE HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 29 FIBRIN SEALANT HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 30 SAH GLOBAL MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
TABLE 31 CARDIOVASCULAR SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 32 GENERAL SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 33 ORTHOPEDIC SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 34 UROLOGY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 35 PULMONOLOGY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 36 NEUROSURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 37 GYNECOLOGY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 38 COSMETIC SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 39 OTHER SAH APPLICATIONS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 40 SAH GLOBAL MARKET REVENUE, BASED ON END-USERS,(2021-2029) ($MN)
TABLE 41 HOSPITALS SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 42 AMBULATORY SURGICAL CENTERS SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 43 OTHER END-USERS SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 44 SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
TABLE 45 NORTH AMERICA SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
TABLE 46 NORTH AMERICA SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 47 NORTH AMERICA NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 48 NORTH AMERICA SYNTHETIC SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 49 NORTH AMERICA ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 50 NORTH AMERICA NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 51 NORTH AMERICA SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 52 NORTH AMERICA HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
TABLE 53 NORTH AMERICA SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
TABLE 54 NORTH AMERICA SAH MARKET REVENUE, BASED ON END-USERS, (2021-2029) ($MN)
TABLE 55 NORTH AMERICA SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
TABLE 56 EUROPE SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
TABLE 57 EUROPE SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 58 EUROPE NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 59 EUROPE SYNTHETIC SEALANTS MARKET REVENUE,BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 60 EUROPE ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 61 EUROPE NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 62 EUROPE SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 63 EUROPE HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
TABLE 64 EUROPE SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
TABLE 65 EUROPE SAH MARKET REVENUE, BASED ON END-USERS,(2021-2029) ($MN)
TABLE 66 EUROPE SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
TABLE 67 APAC SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
TABLE 68 APAC SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 69 APAC NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 70 APAC SYNTHETIC SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 71 APAC ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 72 APAC NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 73 APAC SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 74 APAC HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
TABLE 75 APAC SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
TABLE 76 APAC SAH MARKET REVENUE, BASED ON END USERS, (2021-2029) ($MN)
TABLE 77 APAC SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
TABLE 78 ROW SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
TABLE 79 ROW SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 80 ROW NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 81 ROW SYNTHETIC SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 82 ROW ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
TABLE 83 ROW NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
TABLE 84 ROW SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
TABLE 85 ROW HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
TABLE 86 ROW SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
TABLE 87 ROW SAH MARKET REVENUE, BASED ON END-USERS, (2021-2029) ($MN)
TABLE 88 ROW SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
TABLE 89 ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 90 ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE, BASED ON SEGMENTS, (2019-2021) ($MN)
TABLE 91 ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE, BASED ON SUBSEGMENTS, (2019-2021) ($MN)
TABLE 92 ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE, BASED ON GEOGRAPHY, (2019-2021) ($MN)
TABLE 93 ARTIVION: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
TABLE 94 ARTIVION: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 95 ARTIVION: TOTAL REVENUE, BASED ON SUBSEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 96 ARTIVION: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
TABLE 97 BAXTER INTERNATIONAL, INC.: TOTAL SALES AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
TABLE 98 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 99 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
TABLE 100 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 101 B.BRAUN MELSENGEN AG: TOTAL REVENUE, BASED ON SEGMENTS, (2019-2021) ($MN)
TABLE 102 B.BRAUN MELSENGEN, AG: TOTAL REVENUE, BASED ON GEOGRAPHY, (2019-2021) ($MN)
TABLE 103 BD: TOTAL REVENUE AND R&D EXPENSES, (2020-2022)(Q2) ($MN)
TABLE 104 BD: TOTAL REVENUE BASED ON SEGMENTS, (2020-2022)(Q2) ($MN)
TABLE 105 BD: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q2) ($MN)
TABLE 106 INTEGRA LIFESCIENCE: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
TABLE 107 INTEGRA LIFESCIENCE: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 108 INTEGRA LIFESCIENCE: TOTAL REVENUE, BASED ON SUB-SEGMENTS, (2020-2022)(Q1) ($MN)
TABLE 109 INTEGRA LIFESCIENCE: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
TABLE 110 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
TABLE 111 JOHNSON & JOHNSON: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 112 JOHNSON & JOHNSON: TOTAL REVENUE, BASED ON SUBSEGMENTS, (2020-2022) (Q1) ($MN)
TABLE 113 JOHNSON & JOHNSON: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
TABLE 114 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) ($MN)
TABLE 115 MEDTRONIC, PLC: TOTAL REVENUE, BASED ON SEGMENTS (2020-2022) ($MN)
TABLE 116 MEDTRONIC, PLC: TOTAL REVENUE, BASED ON SUB-SEGMENTS, (2020-2022) ($MN)
TABLE 117 MEDTRONIC, PLC: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) ($MN)
TABLE 118 TELEFLEX: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q2) ($MN)
TABLE 119 TELEFLEX: TOTAL REVENUE, BASED ON SEGMENTS,(2020-2022) (Q2) ($MN)
TABLE 120 TELEFLEX: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
LIST OF FIGURES
FIGURE 1 SAH GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: SAH GLOBAL MARKET
FIGURE 3 SAH GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 SAH GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 SAH GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 SAH GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 SAH GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 SAH GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 SAH GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
FIGURE 11 SURGICAL SEALANTS GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
FIGURE 12 SURGICAL ADHESIVES GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
FIGURE 13 HEMOSTATS GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
FIGURE 14 SAH GLOBAL MARKET SHARE, BASED ON PRODUCTS (2022 V/S 2029) (%)
FIGURE 15 SEALANTS GLOBAL MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 16 NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
FIGURE 17 NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 18 FIBRIN NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
FIGURE 19 ALBUMIN NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
FIGURE 20 SYNTHETIC SEALANTS GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 21 OTHER SYNTHETIC SEALANT GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
FIGURE 22 ADHESIVES GLOBAL MARKET SHARE, BASED ON ORIGIN, (2022 V/S 2029) (%)
FIGURE 23 NATURAL ADHESIVES GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 24 SYNTHETIC ADHESIVES GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 25 HEMOSTATS GLOBAL MARKET SHARE, BASED ON FUNCTION (2022 V/S 2029) (%)
FIGURE 26 SAH GLOBAL MARKET SHARE, BASED ON APPLICATION, (2022) (%)
FIGURE 27 SAH GLOBAL MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
FIGURE 28 SAH GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN) CAGR (%)
FIGURE 29 SAH GLOBAL MARKET SHARE AND REVENUE BASED ON COUNTRY (2022) (%) ($MN)
FIGURE 30 NORTH AMERICA SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
FIGURE 31 NORTH AMERICA SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 32 NORTH AMERICA NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 33 NORTH AMERICA SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 34 NORTH AMERICA ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 35 NORTH AMERICA NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 36 NORTH AMERICA SYNTHETIC ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 37 NORTH AMERICA HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
FIGURE 38 NORTH AMERICA SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
FIGURE 39 NORTH AMERICA SAH MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
FIGURE 40 NORTH AMERICA SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
FIGURE 41 U.S. SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 42 U.S. SAH MARKET REVENUE, BASED ON END-USERS,(2022 V/S 2029) ($MN)
FIGURE 43 REST OF N.A. SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 44 REST OF N.A. SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 45 EUROPE SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
FIGURE 46 EUROPE SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 47 EUROPE NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 48 EUROPE SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 49 EUROPE ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 50 EUROPE NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 51 EUROPE SYNTHETIC ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 52 EUROPE HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
FIGURE 53 EUROPE SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
FIGURE 54 EUROPE SAH MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
FIGURE 55 EUROPE SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
FIGURE 56 GERMANY SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 57 GERMANY SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 58 U.K. SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 59 U.K. SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029)($MN)
FIGURE 60 FRANCE SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 61 FRANCE SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 62 REST OF EUROPE SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 63 REST OF EUROPE SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 64 APAC SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
FIGURE 65 APAC SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 66 APAC NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 67 APAC SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 68 APAC ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 69 APAC NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 70 APAC SYNTHETIC ADHESIVES MARKET SHARE BASED COMPOSITION, (2022 V/S 2029) (%)
FIGURE 71 APAC HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
FIGURE 72 APAC SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
FIGURE 73 APAC SAH MARKET SHARE, BASED ON END USERS, (2022 V/S 2029) (%)
FIGURE 74 APAC SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
FIGURE 75 JAPAN SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 76 JAPAN SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 77 CHINA SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 78 CHINA SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 79 INDIA SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 80 INDIA SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 81 REST OF APAC SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS,(2022 V/S 2029) ($MN)
FIGURE 82 REST OF APAC SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 83 ROW SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
FIGURE 84 ROW SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 85 ROW NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 86 ROW SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 87 ROW ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 88 ROW NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 89 ROW SYNTHETIC ADHESIVES MARKET SHARE BASED COMPOSITION, (2022 V/S 2029) (%)
FIGURE 90 ROW HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
FIGURE 91 ROW SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
FIGURE 92 ROW SAH MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
FIGURE 93 ROW SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
FIGURE 94 BRAZIL SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 95 BRAZIL SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 96 REST OF LATAM SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 97 REST OF LATAM SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 98 MIDDLE EAST & OTHERS SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 99 MIDDLE EAST & OTHERS SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 100 SWOT: ADVANCED MEDICAL SOLUTIONS
FIGURE 101 SWOT: ARTIVION
FIGURE 102 SWOT: BAXTER INTERNATIONAL, INC.
FIGURE 103 SWOT: B.BRAUN MELSUNGEN, AG
FIGURE 104 SWOT: BD (C.R.BARD, INC.)
FIGURE 105 SWOT: CORZA MEDICAL
FIGURE 106 SWOT: INTEGRA LIFESCIENCE
FIGURE 107 SWOT: JOHNSON & JOHNSON (ETHICON)
FIGURE 108 SWOT: MEDTRONIC, PLC
FIGURE 109 SWOT: TELEFLEX
FIGURE 1 SAH GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: SAH GLOBAL MARKET
FIGURE 3 SAH GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 SAH GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 SAH GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 SAH GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 SAH GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 SAH GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 SAH GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
FIGURE 11 SURGICAL SEALANTS GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
FIGURE 12 SURGICAL ADHESIVES GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
FIGURE 13 HEMOSTATS GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
FIGURE 14 SAH GLOBAL MARKET SHARE, BASED ON PRODUCTS (2022 V/S 2029) (%)
FIGURE 15 SEALANTS GLOBAL MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 16 NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
FIGURE 17 NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 18 FIBRIN NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
FIGURE 19 ALBUMIN NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
FIGURE 20 SYNTHETIC SEALANTS GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 21 OTHER SYNTHETIC SEALANT GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
FIGURE 22 ADHESIVES GLOBAL MARKET SHARE, BASED ON ORIGIN, (2022 V/S 2029) (%)
FIGURE 23 NATURAL ADHESIVES GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 24 SYNTHETIC ADHESIVES GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 25 HEMOSTATS GLOBAL MARKET SHARE, BASED ON FUNCTION (2022 V/S 2029) (%)
FIGURE 26 SAH GLOBAL MARKET SHARE, BASED ON APPLICATION, (2022) (%)
FIGURE 27 SAH GLOBAL MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
FIGURE 28 SAH GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN) CAGR (%)
FIGURE 29 SAH GLOBAL MARKET SHARE AND REVENUE BASED ON COUNTRY (2022) (%) ($MN)
FIGURE 30 NORTH AMERICA SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
FIGURE 31 NORTH AMERICA SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 32 NORTH AMERICA NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 33 NORTH AMERICA SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 34 NORTH AMERICA ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 35 NORTH AMERICA NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 36 NORTH AMERICA SYNTHETIC ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 37 NORTH AMERICA HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
FIGURE 38 NORTH AMERICA SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
FIGURE 39 NORTH AMERICA SAH MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
FIGURE 40 NORTH AMERICA SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
FIGURE 41 U.S. SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 42 U.S. SAH MARKET REVENUE, BASED ON END-USERS,(2022 V/S 2029) ($MN)
FIGURE 43 REST OF N.A. SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 44 REST OF N.A. SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 45 EUROPE SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
FIGURE 46 EUROPE SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 47 EUROPE NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 48 EUROPE SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 49 EUROPE ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 50 EUROPE NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 51 EUROPE SYNTHETIC ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 52 EUROPE HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
FIGURE 53 EUROPE SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
FIGURE 54 EUROPE SAH MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
FIGURE 55 EUROPE SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
FIGURE 56 GERMANY SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 57 GERMANY SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 58 U.K. SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 59 U.K. SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029)($MN)
FIGURE 60 FRANCE SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 61 FRANCE SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 62 REST OF EUROPE SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 63 REST OF EUROPE SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 64 APAC SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
FIGURE 65 APAC SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 66 APAC NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 67 APAC SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 68 APAC ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 69 APAC NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 70 APAC SYNTHETIC ADHESIVES MARKET SHARE BASED COMPOSITION, (2022 V/S 2029) (%)
FIGURE 71 APAC HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
FIGURE 72 APAC SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
FIGURE 73 APAC SAH MARKET SHARE, BASED ON END USERS, (2022 V/S 2029) (%)
FIGURE 74 APAC SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
FIGURE 75 JAPAN SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 76 JAPAN SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 77 CHINA SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 78 CHINA SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 79 INDIA SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 80 INDIA SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 81 REST OF APAC SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS,(2022 V/S 2029) ($MN)
FIGURE 82 REST OF APAC SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 83 ROW SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
FIGURE 84 ROW SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 85 ROW NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 86 ROW SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
FIGURE 87 ROW ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
FIGURE 88 ROW NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
FIGURE 89 ROW SYNTHETIC ADHESIVES MARKET SHARE BASED COMPOSITION, (2022 V/S 2029) (%)
FIGURE 90 ROW HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
FIGURE 91 ROW SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
FIGURE 92 ROW SAH MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
FIGURE 93 ROW SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
FIGURE 94 BRAZIL SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 95 BRAZIL SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 96 REST OF LATAM SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 97 REST OF LATAM SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 98 MIDDLE EAST & OTHERS SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
FIGURE 99 MIDDLE EAST & OTHERS SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
FIGURE 100 SWOT: ADVANCED MEDICAL SOLUTIONS
FIGURE 101 SWOT: ARTIVION
FIGURE 102 SWOT: BAXTER INTERNATIONAL, INC.
FIGURE 103 SWOT: B.BRAUN MELSUNGEN, AG
FIGURE 104 SWOT: BD (C.R.BARD, INC.)
FIGURE 105 SWOT: CORZA MEDICAL
FIGURE 106 SWOT: INTEGRA LIFESCIENCE
FIGURE 107 SWOT: JOHNSON & JOHNSON (ETHICON)
FIGURE 108 SWOT: MEDTRONIC, PLC
FIGURE 109 SWOT: TELEFLEX
